EZElisa™富含亮氨酸重复序列的蛋白15（LRRC15）
试剂盒-EZElisa™ Leucine Rich Repeat Containing Protein 15 (LRRC15) Kit- 询价
- Biogradetech
- 美国
- A-QEK07562-96wells
- 2025年07月14日
企业认证
相关产品推荐更多 >
Goat Substance P ELISA Kit/Goat Substance P ELISA Kit
询价
EZElisa™山羊血管内皮细胞生长因子A（VEGF-A）ELISA试剂盒-EZElisa™ Goat Vascular Endothelial cell Growth Factor A (VEGF-A) ELISA Kit
询价
Chicken Fibromodulin ELISA Kit/Chicken Fibromodulin ELISA Kit
询价
EZElisa™ Parvalbumin（PVALB）ELISA试剂盒（英语：ELISA试剂盒）-EZElisa™ Parvalbumin (PVALB) ELISA Kit
询价Canine Haptoglobin Related Protein ELISA Kit/Canine Haptoglobin Related Protein ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
运输过程中保存：2-8℃
- 保质期：
1年
- 英文名：
EZElisa™ Leucine Rich Repeat Containing Protein 15 (LRRC15) Kit
- 库存：
100
- 供应商：
艾美捷科技
EZElisa™富含亮氨酸重复序列的蛋白15（LRRC15）试剂盒，EZElisa™ Leucine Rich Repeat Containing Protein 15 (LRRC15) Kit，富含亮氨酸重复序列的蛋白15（LRRC15）试剂盒, Leucine Rich Repeat Containing Protein 15 (LRRC15) Kit
产品名称：EZElisa™富含亮氨酸的PPR基序蛋白（LRPPRC）试剂盒-EZElisa™ Leucine Rich Repeat Containing Protein 15 (LRRC15) Kit
产品货号：A-QEK07562-96wells
产品规格：96wells
Enzyme Immunoassay for the estimation of EZElisa™ Leucine Rich Repeat Containing Protein 15 (LRRC15) in serum and plasma, tissue homogenates and other biological fluids.
种属：Human
检测方法：比色法
检测范围：0.312 - 20 ng/ml
该EZElisa™富含亮氨酸重复序列的蛋白15（LRRC15）试剂盒ELISA的特点包括：即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证，符合金环标准质量ELISA的要求，这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物，样品可以是血清
运输过程中保存：2-8℃
点击：EZElisa™富含亮氨酸的PPR基序蛋白（LRPPRC）试剂盒-EZElisa™ Leucine Rich Repeat Containing Protein 15 (LRRC15) Kit更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Discovery and Characterization of Leucine-Rich Repeat-Containing G Protein-Coupled Receptors
Leucine-rich repeat-containing G protein-coupled receptors (LGRs) are type A rhodopsin-like GPCRs that include the glycoprotein pituitary hormone receptors for the thyroid-stimulating, follicle-stimulating, and luteinizing hormones (TSH, FSH
Measuring the Activity of Leucine-Rich Repeat Kinase 2: A Kinase Involved in Parkinsons Disease
Mutations in the LRRK2 (Leucine-Rich Repeat Kinase 2) gene are the most common cause of autosomal dominant Parkinson’s disease. LRRK2 has multiple functional domains including a kinase domain. The kinase activity of LRRK2 is implicated
PTEN-induced novel kinase 1 (PINK1) and leucine-rich repeat kinase 2 (LRRK2) are two protein kinases associated with recessive and dominant forms of parkinsonism, respectively. Mutations in PINK1 cause loss of protein function
技术资料暂无技术资料 索取技术资料
